Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?

被引:20
作者
Yaseen H. [1 ,4 ]
Khalaf M. [1 ]
Rashid N. [2 ]
Darwich M. [3 ]
机构
[1] Pediatric/Neonatal Department, Al Qassimi Hospital, Sharjah
[2] Laboratory Department, Al Qassimi Hospital, Sharjah
[3] Pediatrics Department, Al Falah Hospital, Sharjah
[4] Sharjah
关键词
D O I
10.1038/sj.jp.7211356
中图分类号
学科分类号
摘要
Objective: The objective of the study was to determine whether initiation of early phototherapy in positive direct Coombs' test (DCT) with ABO-incompatible newborns would prevent severe jaundice. Study Design: A prospective controlled study was performed at Al Qassimi Hospital. Infants born at term and weighing > 2000 g with ABO incompatibility and a positive DCT were included in the study. Within their first 4hours of life and after parental consent, infants were enrolled into one of two groups: prophylactic phototherapy group, which received phototherapy during the first 24hours of life (group I), or no prophylactic phototherapy, which represents the control group (group II). Selection of infants to either group was by 2-week alternative strategy. Blood group, complete blood count (CBC), reticulocyte count, blood smears, total serum bilirubin (TSB) and DCT were performed on cord blood of all neonates born to mothers with O-positive blood group. CBC, reticulocytes and TSB level were obtained in all enrolled infants at 12, 24, 48, 72, and 96 hours of life. Results: During the study period, 242 newborns with positive DCT were enrolled. A total of 102 infants were allocated to the prophylactic phototherapy arm and 140 as controls. Prophylactic phototherapy was associated with a significant decrease in the TSB at 24 hours (p=0.002) and at 48 hours (p=0.003) but not later on. The total number of patients who had hyperbilirubinemia at any time during the first 96hours was significantly less in the prophylactic group (17 vs 45 - p=0.006). Prolonged hospital stay because of phototherapy was more frequent in the control group (p=0.03). Conclusion: Prophylactic phototherapy was associated with a significant reduction of TSB in the first 48 hours of life but not later on. Clinical benefits of this strategy could not be proven. © 2005 Nature Publishing Group. All rights reserved.
引用
收藏
页码:590 / 594
页数:4
相关论文
共 16 条
[1]  
Maisels J., Kring E., Length of stay, jaundice and hospital readmission, Pediatrics, 101, pp. 995-998, (1998)
[2]  
Mitchell S., Mathura N., Identifying infants who might benefit from routine measurement of bilirubin during first 48-72 hours of life, BMJ, 320, (2000)
[3]  
Stoll B., Kliegman R., Blood disorders, Nelson Textbook of Pediatrics, pp. 599-608, (2004)
[4]  
Sarici S.U., Yurdakok M., Serdan M.A., An early 6-hour serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease, Pediatrics, 109, (2002)
[5]  
Orzalesi M., Gloria F., Lucarelli P., Bottini E., ABO system incompatibility: Relationship between direct Coombs' test positivity and neonatal jaundice, Pediatrics, 51, pp. 288-289, (1973)
[6]  
Maisels M.J., Newman T.B., Kernicterus in otherwise healthy, breast-fed term newborns, Pediatrics, 96, pp. 730-733, (1995)
[7]  
Osborn L.M., Lenarsky C., Oakes R., Reiff M., Phototherapy in full term infants with hemolytic disease secondary to ABO incompatibility, Pediatrics, 74, pp. 371-374, (1984)
[8]  
Bhutani V.K., Johnson L., Sivieri E.M., Predictive ability of pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy and near-term newborns, Pediatrics, 103, pp. 6-14, (1999)
[9]  
Stanley I.P., Chung M., Kulig J., Et al., An evidence-based review of important issues concerning neonatal hyperbilirubinemia, Peditatrics, 114, (2004)
[10]  
Brown A.K., Kim M.H., Wu Y.K., Bryla D.A., Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia, Pediatrics, 75, pp. 393-400, (1985)